Tersera Therapeutics
ZOLADEX
Manufacturer:
Tersera Therapeutics
Name:
ZOLADEX
Category:
J Code
HCPCS:
J9202
NDC(s):
70720-0950-36, 70720-0951-30,
Primary Type:
Cancer
Route of Administration:
Subcutaneous
About:
ZOLADEX is a Cancer drug manufactured by Tersera Therapeutics and administered via the Subcutaneous route of administration. The J Code: J9202 is aligned to the drug ZOLADEX.